Nolvadex CAS NO.54965-24-1

Product Details

xi'an veda chemical co.,ltd, is specializes in apis and intermediates, as well as fine chemical products and customer synthesis.

although don't have long history, the company has an increasing output products. our products have been exporting to south america,

southeast asia, europe and other regions, and has gained excellent reputation.

to decrease the pain of the patient is our mission.

we are trying every effort to make the worlds more healthier and happier.

tamoxifen citrate is commonly prescribed for:

1) blocking the effects of estrogen

2) treatment of breast cancer

3) decreases the chance of breast cancer coming back in women who have received treatment for the disease

4) may help prevent breast cancer in women who have a high risk of developing breast cancer.

if you are pharmaceutical company that are searching for tamoxifen

citrate, or you are a trading company that are looking for effective

products to treat breast cancer, please contact us.

we would like to offer our best quotation for you. what's more, the coa/msds/moa of tamoxifen citrate can be offered.

we, xi'an veda chemical, is ready to make long term cooperation with you.

product name	tamoxifen citrate
synonyms	(z)-2-[4-(1,2-diphenyl-1-butenyl)phenoxyl]-n,n-dimethyl-ethanamine-citrate; 1-p-beta-dimethylaminoethoxyphenyl-trans-1,2-diphenylbut-1-ene citrate; tamoxiphen citrate; 2-{4-[(1e)-1,2-diphenylbut-1-en-1-yl]phenoxy}-n,n-dimethylethanamine 2-hydroxypropane-1,2,3-tricarboxylate (salt)
molecular formula	c₃₂h₃₄no₈
molecular weight	560.6159
inchi	inchi=1/c26h29no.c6h8o7/c1-4-25(21-11-7-5-8-12-21)26(22-13-9-6-10-14-22)23-15-17-24(18-16-23)28-20-19-27(2)3;7-3(8)1-6(13,5(11)12)2-4(9)10/h5-18h,4,19-20h2,1-3h3;13h,1-2h2,(h,7,8)(h,9,10)(h,11,12)/p-3/b26-25-;
cas registry number	54965-24-1
einecs	259-415-2
molecular structure
melting point	140-144℃
water solubility	slightly soluble
hazard symbols	t:toxic;
risk codes	r22:; r45:;
safety description	s45:; s53:;

characters	white or almost white, crystalline powder
identification	ir: complies with the crs
	ultraviolet absorption: complies with working standard
loss on drying	not more than 0.5%
residue on ignition	not more than 0.2%
limit of e-isomer	not more than 0.3%
iron	maximum 50ppm
heavy metals	maximum 10ppm
related impurities	single peak area: not greater than 0.5%
	total peak area: not greater than 1.0%
assay	tamoxifen citrate contains not less and 99.0% percent and not more than 101.0 percent of c₂₆h₂₉no·c₆h₈o₇, calculated on the dried basis